1960
DOI: 10.1001/archsurg.1960.01300050005002
|View full text |Cite
|
Sign up to set email alerts
|

Progressive Malignant Degeneration of a Cystadenoma of the Pancreas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

1971
1971
2007
2007

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(6 citation statements)
references
References 11 publications
0
6
0
Order By: Relevance
“…Clinical, pathological, and molecular observations have established that a mucinous cystic neoplasm with mild dysplasia can progress to a mucinous cystic neoplasm with moderate dysplasia, and from there to mucinous cystic neoplasm with carcinoma in situ. Furthermore, it is clear that if left untreated, noninvasive mucinous cystic neoplasms can progress to invasive carcinoma . For example, molecular analyses have documented that the progression from mucinous cystic neoplasm with low‐grade dysplasia to mucinous cystic neoplasm with an associated invasive carcinoma is associated with the progressive accumulation of genetic alterations in cancer‐associated genes, including KRAS , TP53 , and SMAD4/DPC4 .…”
Section: Mucinous Cystic Neoplasmsmentioning
confidence: 99%
“…Clinical, pathological, and molecular observations have established that a mucinous cystic neoplasm with mild dysplasia can progress to a mucinous cystic neoplasm with moderate dysplasia, and from there to mucinous cystic neoplasm with carcinoma in situ. Furthermore, it is clear that if left untreated, noninvasive mucinous cystic neoplasms can progress to invasive carcinoma . For example, molecular analyses have documented that the progression from mucinous cystic neoplasm with low‐grade dysplasia to mucinous cystic neoplasm with an associated invasive carcinoma is associated with the progressive accumulation of genetic alterations in cancer‐associated genes, including KRAS , TP53 , and SMAD4/DPC4 .…”
Section: Mucinous Cystic Neoplasmsmentioning
confidence: 99%
“…The natural history of mucinous cystic tumor of the pancreas has been considered to indicate exceedingly slow growth, as judged by the relative lack of tendency to infiltrate adjacent tissues and organs, the good second chances for a complete resection even several years after the first operation, and the low likelihood of distant metastasis. 1,8,11,15 Nevertheless, there are few reports of the natural history of mucinous cystic tumor of the pancreas, because most neoplastic cystic lesions are resected at the time of diagnosis. The present patient was diagnosed as having mucinous cystadenoma on the basis of the histopathologic findings of the cyst wall biopsy specimen taken at the time of cystgastrostomy, but complete resection of the cystic mass was possible 11 years later.…”
Section: Discussionmentioning
confidence: 99%
“…However, cystadenocarcinoma may arise from preexisting cystadenoma (Glenner and Mallory, 1956;Cornes and Azzopardi, 1959). The evidence of this is: (1) Similarity of sites of origin and similar age and sex distribution (Probstein and Blumenthal, 1960). (2) The existence of benign and malignant areas in the same tumor with transition between the two (Glenner and Mallory, 1956).…”
Section: Commentmentioning
confidence: 99%
“…(2) The existence of benign and malignant areas in the same tumor with transition between the two (Glenner and Mallory, 1956). (3) The development of cystadenocarcinoma in a benign cystadenoma, followed for several years (Lichtenstein, 1934;Probstein and Blumenthal, 1960). stressed, as their treatment differs markedly from that of the more common cysts of the pancreas (e.g., pseudocysts, retention cysts, etc.).…”
Section: The Incidence Sex and Age Distribution And Clinical Featurmentioning
confidence: 99%